Literature DB >> 15771228

In vitro and ex vivo intestinal tissue models to measure mucoadhesion of poly (methacrylate) and N-trimethylated chitosan polymers.

Simon Keely1, Atvinder Rullay, Carolyn Wilson, Adrian Carmichael, Steve Carrington, Anthony Corfield, David M Haddleton, David J Brayden.   

Abstract

PURPOSE: The adhesion of a range of polymers based on poly(2-(dimethylamino-ethyl) methacrylate (pDMAEMA) was assessed using human mucus-secreting and non mucus-secreting intestinal cell monolayers, HT29-MTX-E12 (E12) and HT29 monolayers, as well as excised non-everted intestinal sacs from rats. Differentiation of mucoadhesion from bioadhesion was achieved by pre-treatment with the mucolytic agent, N-acetyl cysteine (NAC). Adherence of pDMAEMA polymers was compared to that obtained with the mucoadhesive, N-trimethylated chitosan (TMC).
METHODS: The quantity of adherent coumarin 343-conjugated polymers to HT29, E12, and intestinal sacs was measured by fluorescence. Confocal laser scanning microscopy (CLSM), light microscopy, and fluorescent microscopy were used to provide direct evidence. Measurements of transepithelial electrical resistance (TEER), permeability to FITC-dextran 4000 (FD-4), and the release of lactate dehydrogenase (LDH) were used to assess potential cytotoxicity of polymers.
RESULTS: Adherence of unquaternized and of 10%, 24%, and 32% methyl iodide-quaternized pDMAEMA polymers was measured in E12, HT29, and sacs. All pDMAEMA polymers showed significantly higher levels of adhesion to mucus (mucoadhesion) than to epithelium (bioadhesion). Colocalization of pDMAEMA with mucus was confirmed in E12 by microscopy. TMC showed equally high levels of mucoadhesion as unquaternized and 24% quaternized pDMAEMA, but displayed higher levels of bioadhesion. pDMAEMA-based polymers demonstrated lower levels of adherence to E12 and rat sacs in the presence of NAC, whereas adherence of TMC was unchanged. pDMAEMA significantly decreased the permeability of FD-4 across E12 monolayers and sacs and was less cytotoxic in E12 than in HT29. In contrast, TMC increased the permeability of FD-4 across E12 and sacs and was less cytotoxic in E12 than in HT29.
CONCLUSIONS: Human mucus-producing E12 monolayers can be used to assess polymer mucoadhesion and give similar data to isolated rat intestinal sacs. pDMAEMA displayed similar levels of mucoadhesion and lower levels of bioadhesion than a chitosan derivative and it was not cytotoxic. pDMAEMA decreased FD-4 flux in the presence of mucus, whereas TMC increased it. The combination of mucus and methacrylate polymers appears to increase barrier function of the apical membrane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771228     DOI: 10.1007/s11095-004-9007-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  54 in total

Review 1.  Biopolymer mucoadhesives.

Authors:  S E Harding; S S Davis; M P Deacon; I Fiebrig
Journal:  Biotechnol Genet Eng Rev       Date:  1999

Review 2.  Multifunctional matrices for oral peptide delivery.

Authors:  A Bernkop-Schnürch; G Walker
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2001       Impact factor: 4.889

3.  Effect of chitosan on epithelial cell tight junctions.

Authors:  Jennifer Smith; Edward Wood; Michael Dornish
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

4.  A conditionally immortalized epithelial cell line for studies of intestinal drug transport.

Authors:  S Tavelin; V Milovic; G Ocklind; S Olsson; P Artursson
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

5.  Synthetic polymers alter the structure of cervical mucus.

Authors:  R K Willits; W M Saltzman
Journal:  Biomaterials       Date:  2001-03       Impact factor: 12.479

6.  Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models.

Authors:  C Meaney; C O'Driscoll
Journal:  Eur J Pharm Sci       Date:  1999-07       Impact factor: 4.384

7.  Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride.

Authors:  Dewald Snyman; Josias H Hamman; Awie F Kotze
Journal:  Drug Dev Ind Pharm       Date:  2003-01       Impact factor: 3.225

8.  Permanent, nonleaching antibacterial surfaces. 1. Synthesis by atom transfer radical polymerization.

Authors:  Sang Beom Lee; Richard R Koepsel; Scott W Morley; Krzysztof Matyjaszewski; Yujie Sun; Alan J Russell
Journal:  Biomacromolecules       Date:  2004 May-Jun       Impact factor: 6.988

9.  Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass.

Authors:  V M Leitner; M K Marschütz; A Bernkop-Schnürch
Journal:  Eur J Pharm Sci       Date:  2003-01       Impact factor: 4.384

10.  An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine.

Authors:  L Barthe; J F Woodley; S Kenworthy; G Houin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.569

View more
  13 in total

1.  Stomach-specific controlled release gellan beads of acid-soluble drug prepared by ionotropic gelation method.

Authors:  Mrunalini Narkar; Praveen Sher; Atmaram Pawar
Journal:  AAPS PharmSciTech       Date:  2010-02-24       Impact factor: 3.246

2.  Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease.

Authors:  Sean W Mateer; Jocelle Cardona; Ellen Marks; Bridie J Goggin; Susan Hua; Simon Keely
Journal:  J Vis Exp       Date:  2016-02-09       Impact factor: 1.355

3.  Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties.

Authors:  Abofu Alemka; Marguerite Clyne; Fergus Shanahan; Thomas Tompkins; Nicolae Corcionivoschi; Billy Bourke
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 4.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

Authors:  Samuel K Lai; Ying-Ying Wang; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2008-12-13       Impact factor: 15.470

5.  Interaction between transcellular and paracellular water transport pathways through Aquaporin 5 and the tight junction complex.

Authors:  Jitesh D Kawedia; Michelle L Nieman; Gregory P Boivin; James E Melvin; Ken-Ichiro Kikuchi; Arthur R Hand; John N Lorenz; Anil G Menon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

6.  Dexamethasone-pDMAEMA polymeric conjugates reduce inflammatory biomarkers in human intestinal epithelial monolayers.

Authors:  Simon Keely; Sinéad M Ryan; David M Haddleton; Adam Limer; Giuseppe Mantovani; Evelyn P Murphy; Sean P Colgan; David J Brayden
Journal:  J Control Release       Date:  2008-12-06       Impact factor: 9.776

7.  A tertiary amino-containing polymethacrylate polymer protects mucus-covered intestinal epithelial monolayers against pathogenic challenge.

Authors:  Simon Keely; Lee-Anne B Rawlinson; David M Haddleton; David J Brayden
Journal:  Pharm Res       Date:  2007-11-29       Impact factor: 4.200

8.  Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction.

Authors:  Michael Fricker; Bridie J Goggins; Sean Mateer; Bernadette Jones; Richard Y Kim; Shaan L Gellatly; Andrew G Jarnicki; Nicholas Powell; Brian G Oliver; Graham Radford-Smith; Nicholas J Talley; Marjorie M Walker; Simon Keely; Philip M Hansbro
Journal:  JCI Insight       Date:  2018-02-08

Review 9.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

10.  Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia.

Authors:  Simon Keely; Louise E Glover; Thomas Weissmueller; Christopher F MacManus; Sophie Fillon; Blair Fennimore; Sean P Colgan
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.